The CSF T-tau and P-tau levels did not change during follow-up in the HCs and PD group, however, we detected a significant increase in the level of CSF T-tau after two years (p = 0.036) and CSF P-tau after six months from baseline in SWEDD subjects (p = 0.011). The gene discussed is OCA2; the disease is Parkinson disease.